Literature DB >> 15114493

Kava Hepatotoxicity: Are we any closer to the truth?

Jennifer Anke1, Iqbal Ramzan.   

Abstract

In recent years, kava kava ( Piper methysticum, Forst. f., Piperaceae) has been implicated in a number of liver failure cases. Ever since this has kept the scientific world busy. Even though, on closer inspection, the majority of the case reports are probably not connected to kava intake, hepatotoxic effects of kava cannot generally be ruled out. In this article the major theories as to the mechanism of kava hepatotoxicity are summarized. But in spite of all these hypotheses, there is still no satisfactory answer. In any case, further studies, that might hopefully restore the reputation of kava, are required.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114493     DOI: 10.1055/s-2004-815533

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  10 in total

1.  Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract.

Authors:  Natasha P Clayton; Katsuhiko Yoshizawa; Grace E Kissling; Leo T Burka; Po-Chuen Chan; Abraham Nyska
Journal:  Exp Toxicol Pathol       Date:  2006-10-23

2.  Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava.

Authors:  Mamta Behl; Abraham Nyska; Rajendra S Chhabra; Gregory S Travlos; Laurene M Fomby; Barney R Sparrow; Milton R Hejtmancik; Po C Chan
Journal:  Food Chem Toxicol       Date:  2011-08-18       Impact factor: 6.023

3.  Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents.

Authors:  Jun Wang; Weiyue Qu; Harry C Bittenbender; Qing X Li
Journal:  J Food Sci Technol       Date:  2013-06-25       Impact factor: 2.701

Review 4.  Complementary and alternative medicine in the treatment of chronic liver disease.

Authors:  Robert G Batey; Ses J Salmond; Alan Bensoussan
Journal:  Curr Gastroenterol Rep       Date:  2005-02

5.  Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.

Authors:  Ahmad Ali Shaik; David Lee Hermanson; Chengguo Xing
Journal:  Bioorg Med Chem Lett       Date:  2009-08-06       Impact factor: 2.823

6.  Identification and characterization of kava-derived compounds mediating TNF-alpha suppression.

Authors:  Michael P Pollastri; Adrian Whitty; Jamie Cassidy Merrill; Xiaoren Tang; Trent D Ashton; Salomon Amar
Journal:  Chem Biol Drug Des       Date:  2009-06-16       Impact factor: 2.817

7.  Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract.

Authors:  Lei Guo; Quanzhen Li; Qingsu Xia; Stacey Dial; Po-Chuen Chan; Peter Fu
Journal:  Food Chem Toxicol       Date:  2008-12-07       Impact factor: 6.023

Review 8.  Toxicity of kava kava.

Authors:  Peter P Fu; Qingsu Xia; Lei Guo; Hongtao Yu; Po-Chuen Chan
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2008 Jan-Mar       Impact factor: 3.781

9.  Flavokawains a and B in kava, not dihydromethysticin, potentiate acetaminophen-induced hepatotoxicity in C57BL/6 mice.

Authors:  Sreekanth C Narayanapillai; Pablo Leitzman; M Gerard O'Sullivan; Chengguo Xing
Journal:  Chem Res Toxicol       Date:  2014-09-12       Impact factor: 3.739

Review 10.  Kava as a Clinical Nutrient: Promises and Challenges.

Authors:  Tengfei Bian; Pedro Corral; Yuzhi Wang; Jordy Botello; Rick Kingston; Tyler Daniels; Ramzi G Salloum; Edward Johnston; Zhiguang Huo; Junxuan Lu; Andrew C Liu; Chengguo Xing
Journal:  Nutrients       Date:  2020-10-05       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.